Organicell

Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six Weeks.

Too bad we don't trade for a living! We don't even use real-time quotes, LOL. $0.02 to $0.27, from Easter - what...
Organicell

Organicell (BPSR) a Triple Since Easter.

Slowly she turns, step-by-step. $20 million gain in market value. Spurred by FDA Emergency IND's. RELATED: Adding Organicell (BPSR)...

Citius Pharma (CTXR) Seeks Expeditious Pathway Into the Clinic, for CoronaVirus Related Acute Respiratory...

Sumbmits pre-IND Into Coronavirus Treatment Acceleration Program (CTAP).   Citius Announces Pre-IND Submission to FDA Under the Coronavirus...

‘Amazing potential.’ UM doctor to start stem cell trial for coronavirus patients (Miami Herald)

BY BEN CONARCK APRIL 16, 2020 A team of doctors at the University of Miami won emergency federal approval...

FDA Authorizes Athersys (ATHX) to Initiate a Pivotal Clinical Trial!

FDA Authorizes Athersys to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome.

Athersys (ATHX) Overview and Due Diligence links (Reddit)

I've (Dalek on Reddit) compiled a list of links that might be useful if you are disorganized like myself. If you are...

Latest article

Smart for Life (SMFL) Capitulates?

We Are Long Term Bullish on Smart for Life. After a Volatile Post IPO Trading, we may Have Seen the Bottom....

Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Novogratz Remains Steadfast on Crypto, Says Wait Until Next Year (Bloomberg)

Great call. This was actually from Late 2018. (Bloomberg) — Billionaire investor Michael Novogratz is resolute when it...